Related references
Note: Only part of the references are listed.Circulating Tumor Cells: From Bench to Bedside
Marija Balic et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Differences in the expression of epithelial-mesenchymal transition related molecules between primary tumors and pulmonary metastatic tumors in colorectal cancer
Hidenori Kouso et al.
SURGERY TODAY (2013)
Combined Modality Therapy for Rectal Cancer: The Relative Value of Posttreatment Versus Pretreatment CEA as a Prognostic Marker for Disease Recurrence
Suisui Song et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients
I. Tarantino et al.
BRITISH JOURNAL OF CANCER (2012)
Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy
Aneel Bhangu et al.
SURGICAL ONCOLOGY-OXFORD (2012)
Clinical Significance of Pre- to Post-Chemoradiotherapy s-CEA Reduction Ratio in Rectal Cancer Patients Treated with Preoperative Chemoradiotherapy and Curative Resection
Chan Wook Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood
Siyang Zheng et al.
BIOMEDICAL MICRODEVICES (2011)
Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients
S. C. C. Wong et al.
BRITISH JOURNAL OF CANCER (2011)
Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer
Satoshi Matsusaka et al.
CANCER SCIENCE (2011)
Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
Veronique Hofman et al.
CLINICAL CANCER RESEARCH (2011)
Isolation of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Using a Novel Cell Separation Strategy
Wen Xu et al.
CLINICAL CANCER RESEARCH (2011)
Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer
Jen-Kou Lin et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)
Epithelial-Mesenchymal Transition (EMT) Protein Expression in a Cohort of Stage II Colorectal Cancer Patients With Characterized Tumor Budding and Mismatch Repair Protein Status
David Kevans et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2011)
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
J. Tol et al.
ANNALS OF ONCOLOGY (2010)
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients withMetastaticBreast Colorectal and Prostate Cancer
M. Craig Miller et al.
JOURNAL OF ONCOLOGY (2010)
CARCINOEMBRYONIC ANTIGEN AS A PREDICTOR OF PATHOLOGIC RESPONSE AND A PROGNOSTIC FACTOR IN LOCALLY ADVANCED RECTAL CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMORADIOTHERAPY AND SURGERY
Ji Won Park et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Circulating tumor cells in colorectal cancer:: correlation with clinical and pathological variables
J. Sastre et al.
ANNALS OF ONCOLOGY (2008)
Detection of Survivin-Expressing Circulating Cancer Cells (CCCs) in Peripheral Blood of Patients with Gastric and Colorectal Cancer Reveals High Risks of Relapse
Shang-mian Yie et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers
Kunihiko Hiraiwa et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Prognostic Relevance of Occult Nodal Micrometastases and Circulating Tumor Cells in Colorectal Cancer in a Prospective Multicenter Trial
Kazuo Koyanagi et al.
CLINICAL CANCER RESEARCH (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Preoperative chemoradiation followed by transanal excision for rectal cancer
Jung Wook Huh et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancer
Silke Lankiewicz et al.
MOLECULAR ONCOLOGY (2008)
Cancer screening in the United States, 2007: A review of current guidelines, practices, and prospects
Robert A. Smith et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancer
Jorge A. Garcia et al.
BJU INTERNATIONAL (2007)
The clinical significance of circulating tumor cells in the peripheral blood
Yahya I. Elshimali et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2006)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
Gershon Y. Locker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Circulating tumor cells: the 'leukemic phase' of solid cancers
S Mocellin et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy:: Is there a benefit in using functional imaging?
T Denecke et al.
EUROPEAN RADIOLOGY (2005)
Frequent EpCam protein expression in human carcinomas
PT Went et al.
HUMAN PATHOLOGY (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia
KT Hoffmann et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2002)
Local excision of T2 and T3 rectal cancers after downstaging chemoradiation
CJ Kim et al.
ANNALS OF SURGERY (2001)
The effect of fecal occult-blood screening on the incidence of colorectal cancer
JS Mandel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
